Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

Washington: PATH Gets Gates Grant of $27.8 Million to Improve Access to Cancer Vaccine

June 7, 2006

On Monday, the Seattle-based non-profit Program for Appropriate Technology in Health (PATH) announced it had received a grant from the Bill & Melinda Gates Foundation to identify and overcome obstacles to distributing a human papillomavirus vaccine in poor nations. Two types of HPV are believed to cause 70 percent of cervical cancer cases. "Cervical cancer disproportionately affects women in developing countries because infrastructure is lacking," said Dr. Jacqueline Sherris, director of the cervical cancer program at PATH. Together with the World Health Organization and drug makers Merck and GlaxoSmithKline, PATH will conduct research to reduce barriers to the HPV vaccine in India, Peru, Uganda and Vietnam.

Back to other news for June 7, 2006

Adapted from:
Seattle Post-Intelligencer
06.06.06


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News

Tools
 

Advertisement